Boots MILITARY

Direct Defence Contracting & Procurement

No public evidence identified of any contract, tender award, or memorandum of understanding between Boots (the UK pharmacy/health-and-beauty retailer, part of the former Walgreens Boots Alliance, now The Boots Group) and the Israeli Ministry of Defence, the IDF, the Israel Prison Service, or the Israel Border Police. Searches for “Boots” alongside military-contract terminology returned only unrelated results: a UK Ministry of Defence tender for literal combat-boot footwear (“Development & Supply of Knee Mounted Service Boots,” published 21 Jan 2025) awarded independently of the retailer ¹, and reporting on the unrelated Israeli military bootmaker “Brill” ². Neither result concerns the Boots retail company, and no FMS, DSCA, or UK government contract record naming Boots as a defence contractor or subcontractor has been identified ^{1, 2}.

Separately, two UK-domestic, non-procurement relationships between Boots and the UK defence establishment are documented and should be recorded for completeness. First, Boots UK Limited’s Chief Customer and Category Officer, Steve Ager, signed the UK Armed Forces Covenant on 26 January 2023 at the Lincoln High Street store, with Mark Rigden (Head of Flagships) signing on behalf of Boots Opticians ³. The Covenant is a voluntary, non-contractual employer pledge administered by the Reserve Forces’ and Cadets’ Associations (RFCA), not the Ministry of Defence directly; Boots UK Limited’s GOV.UK register entry lists pledge categories (Armed Forces Friendly; UK Service Veterans and Leavers; UK Service Spouses and Partners; UK Reservists; UK Cadets; Armed Forces Day; Reserve Forces Day; Armed Forces Charities) plus bespoke commitments - a “Forces Network,” a mentoring scheme pairing ex-Forces staff with new recruits from the Forces, and Armed Forces Covenant/Employer Recognition Scheme (ERS) logos on the Boots careers website ⁴. Boots’ own release describes supporting commitments: extra paid annual leave for Reservists during training/mobilisation, relocation support for “Forces Families” spouses/partners between store locations, and the “Valour” internal Business Resource Group (established early 2022) for veterans, reservists, and military families; it also discloses that Boots previously worked with the Army during the Covid-19 pandemic to train Army personnel on swabbing techniques, an auxiliary public-health collaboration rather than a defence-sector contract ³. Then-Minister for Defence People, Veterans and Service Families Dr Andrew Murrison is quoted welcoming the signing ³.

Second, Boots (jointly with No7 Beauty Company, per Boots’ own account) was named among more than 200 employers receiving the Ministry of Defence/RFCA Defence Employer Recognition Scheme (ERS) Gold Award, announced 21 July 2025 and confirmed by Boots on 22 July 2025 ^{5, 6, 7}. The official MoD/RFCA release names Boots but does not independently mention No7 Beauty Company; that specific attribution rests solely on Boots’ own press release, and no independent third-party confirmation of No7’s inclusion was identified ^{5, 6}. Gold-tier criteria per the official release require employers to provide at least 10 days’ extra paid leave for reservists, adopt HR policies supporting veterans and cadet force adult volunteers, “promote defence” across their sector/networks, and demonstrate sustained commitment beyond minimum requirements ⁵. Minister for Veterans and People Al Carns DSO OBE MC MP is quoted framing awarded employers as “crucial partners in protecting our security and boosting the economy,” and Steve Ager (by then titled Chief Commercial Officer and executive sponsor of the Boots Armed Forces Alliance resource group) welcomed the recognition ^{5, 6}. A corroborating East Midlands RFCA news item dated 2 February 2023 referencing the Lincoln signing was identified only as a search snippet and was not independently fetched, so it is noted as unverified secondary corroboration rather than an established source ⁸.

Every primary document reviewed - Boots’ own two releases, the GOV.UK Covenant register entry, and the official MoD/RFCA ERS press release - concerns HR, employer-recognition, and veteran/reservist employment policy exclusively; none describes, states, or implies any commercial, financial, procurement, grant, or supply relationship between Boots and the Ministry of Defence ^{3, 6, 4, 5}. These facts are accordingly recorded as a verified, named, continuing (as of the 2025 award) Boots–UK-Defence-apparatus relationship of record in the employer/HR-engagement domain; they neither establish nor disconfirm any defence-procurement relationship, and the “no public evidence identified” finding on direct defence contracting stated above stands unchanged ^{3, 6, 4, 5}.

Dual-Use Products & Tactical Variants

No public evidence identified of Boots manufacturing, distributing, or marketing any dual-use product line or tactical-variant equipment.

Heavy Machinery, Construction & Infrastructure

No public evidence identified of Boots engaging in heavy machinery manufacturing, construction contracting, or infrastructure development of any kind relevant to military or defence end-use.

Supply Chain Integration with Defence Primes

No public evidence identified linking Boots, as a corporate entity, to any defence-prime supply chain, teaming agreement, or subcontracting relationship. A targeted search for Executive Chairman and former controlling shareholder Stefano Pessina’s name alongside “Israel,” “Elbit,” and “Rafael” returned no reporting connecting him to Israeli defence-sector donations, equity holdings, or directorships ⁹. Pessina’s publicly available biography records no defence-industry directorship and no Israel/Palestine-linked activity ⁹. Incoming Boots Group Chairperson Ornella Barra, Managing Director Anthony Hemmerdinger, incoming CEO Alex Baldock, and controlling private-equity owner Sycamore Partners were each named in corporate leadership disclosures ¹⁰, but no independent search for Israel- or defence-sector ties to any of these four principals was completed in the underlying research, leaving this an open gap rather than a confirmed absence.

The corporate ownership chain has since been further clarified and is in transition. Companies House’s live Persons with Significant Control (PSC) register for Alliance Boots Holdings Limited (company no. 04452715) was re-fetched live in this audit cycle and continues to list exactly one active PSC, Wba Acquisitions Uk Holdco 7 Limited (company no. 8155146), notified 6 April 2016, holding 75%+ of shares and voting rights and the right to appoint/remove directors, with the page summary reading “1 active person with significant control / 0 active statements” and no ceased PSCs shown ¹¹. This re-verification directly confirms - rather than corrects - the prior audit’s statement: the entry has not been updated to reflect either the August 2025 Sycamore Partners completion or the pending Wittington Investments/Fairfax transaction, meaning the live UK PSC record still reflects the pre-2025, Walgreens Boots Alliance-era structure rather than the current or prospective one ¹¹. A secondary, unresolved lead surfaced in search results (but not independently fetched) suggests third-party company-data mirror sites report a different controlling entity, “NO7 Beauty Company Limited,” notified 10 June 2021; these mirrors explicitly admit to carrying only stale data through 2022 and were not opened, so this is flagged as an unresolved discrepancy rather than an established correction to the official Companies House page ¹¹.

Separately, law firm Skadden, Arps, Slate, Meagher & Flom LLP, which advised the buyer, confirms that Wittington Investments, Limited (the Weston family’s Canadian holding company), partnering with Fairfax Financial Holdings Limited, has agreed to acquire The Boots Group from Sycamore Partners and the Pessina family for a total purchase price of $8.9 billion including assumed debt, subject to regulatory approvals and customary closing conditions, with completion expected in Q1 2027 ¹². This is corroborated by contemporaneous reporting citing a £6.7bn headline figure (ITV News) and $8.9bn figures (Pulse2, Cosmetics Business), with the discrepancy likely reflecting currency and debt-inclusion framing rather than a genuine factual conflict ^{13, 14, 15}. Search-result synthesis additionally suggests exclusion of Farmacias Benavides (Mexico) and Alliance Healthcare Deutschland (Germany) from the deal, a resulting 50% post-closing Fairfax equity stake with Wittington retaining operational control, Galen Weston becoming chairman at closing, and Alex Baldock remaining CEO - but these four sub-claims rest on unverified search-snippet synthesis rather than a primary document and are flagged as unconfirmed rather than established ^{13, 14, 15}. A newer, unresolved search-snippet lead - a Retail Gazette headline dated August 2026, “Boots future in doubt after Weston family slashes £7bn offer” - appears to conflict with this Skadden-sourced completion narrative, suggesting the Wittington/Weston offer may have been reduced or renegotiated at some point in 2026; this headline was not independently fetched and is recorded as an unresolved gap rather than a correction to ¹²–¹⁵, since it does not by itself disconfirm the already-cited Skadden announcement ¹⁶.

Stefano Pessina’s precise post-Sycamore equity percentage remains undocumented from a primary filing, and this audit cycle’s research upgrades that finding by documenting a material conflict in the press record rather than resolving it. Financial Times reporting relayed by Chain Drug Review (18 Mar 2025, citing “people familiar with the matter”; FT states Pessina and Sycamore declined comment) and a contemporaneous Reuters-combined wire story report that Pessina’s pre-deal Walgreens Boots Alliance-level stake of roughly 17% was expected to “almost double” to approximately 30% under the deal structure ¹⁷. By contrast, Retail Gazette (12 May 2025), citing The Times, reports that Pessina “will increase his stake in the UK pharmacy group to nearly 50%” - though Retail Gazette’s own text is ambiguous as to whether “the UK pharmacy group” denotes Boots UK specifically or loosely denotes WBA/the post-split Boots entity, and the article supplies no primary-filing citation ¹⁸. A retailsector.co.uk headline echoing the same Times-sourced ~50% figure was identified only as a search snippet and not independently fetched ¹⁹. Sycamore’s own 27 August 2025 completion press release reportedly states the deal closed “in partnership with Stefano Pessina and his family, who have reinvested 100% of their interests in WBA,” but gives no final percentage in available synthesis; the release itself could not be retrieved directly (HTTP 403 on fetch, an archive.org mirror blocked at the tool level, and an alternate Reuters-reprint mirror failing with a connection error), so this remains a search-snippet-only claim rather than a verified primary citation ²⁰. The Boots Group’s own press release on post-acquisition positioning was identified as a lead but not independently fetched this cycle and may contain a company-stated ownership structure ²¹. No SEC Schedule 13D/A, Form 4, or 8-K stating Pessina’s exact resulting ownership percentage was located by search; consequently, no public evidence identified of a primary filing confirming his final percentage, and the existing audit’s “undocumented from a primary filing” conclusion stands confirmed, now with the added, documented nuance that the secondary press record itself is internally inconsistent between a ~30% figure and a “nearly 50%” figure ^{18, 17, 20, 19, 21}.

Logistical Sustainment & Base Services

No public evidence identified of Boots providing logistical sustainment, base-operating, or facilities-support services to any military customer, domestic or foreign.

Munitions, Weapons Systems & Strategic Platforms

No public evidence identified of Boots’ involvement in the manufacture, sale, or distribution of munitions, weapons systems, or strategic military platforms.

Export Licensing, Regulatory & Legal History

No public evidence identified of any export-control classification, licensing action, or regulatory/legal history tying Boots to defence-related export licensing. No UK parliamentary question, OECD National Contact Point complaint, or court filing naming Boots in connection with Israel, Palestine, or occupied-territory commerce was identified, though this reflects a time-boxed search rather than an exhaustive parliamentary or court-docket review ²². Searches instead surfaced unrelated material: general UK government answers on settlement-goods labelling and reporting on a different retailer, Superdrug, discontinuing Ahava-brand products ²². A targeted search for Boots’ name within the Israeli Ministry of Defence’s SIBAT defence-export directory (a biennial catalogue of Israeli defence-industry exporters, participation in which is voluntary and each listed transaction requires a separate export licence) returned no mention of Boots in any located edition reference (2013/14, 2015/16, 2018/19); the directory PDFs themselves were not opened and full-text-checked, so this is a search-snippet-level absence rather than a document-verified one ²³.

Civil Society Scrutiny & Documented Investigations

A BDS Movement campaign page, published 23 July 2008, constitutes one civil-society document addressing Boots’ Israel-adjacent commercial activity ²⁴. The page claims Boots was reportedly in talks to open pharmacy franchises in Israel via the “New Pharm” chain and to expand its range of Israeli-manufactured pharmaceutical and cosmetic products from named suppliers including CTS, Hlavin Industries, Ein Gedi, NanoDerma, Card Guard, Second Opinion, TransPharma Medical, and Tulip Medical ²⁴. The same page claims Boots previously stocked Ahava Dead Sea cosmetics manufactured at Mitspe Shalem, identified in the source as a settlement in the Jordan Valley near Jericho in the West Bank, and that an informal customer-service inquiry indicated the products had been discontinued by 2008 with no reason given ²⁴.

This underlying 2008 story has since been independently verified against a live, directly-fetched primary copy of the Jewish Chronicle article the BDS page paraphrased, superseding the dead-link status previously recorded for that source ²⁵. The Jewish Chronicle article (Simon Griver, 23 May 2008) reports that Boots was “understood to be negotiating” with New Pharm - then Israel’s second-largest pharmacy chain (56 stores, 30 department-store concessions, 2007 sales of £131 million) - to rebrand New Pharm’s shops as “Boots Israel” on a franchise basis ²⁵. The article carries Boots’ own on-record, dated response: “We do not operate any pharmacy or wholesale activity at present in Israel and we do not comment on market speculation” - a direct 2008 corporate denial of then-current Israeli pharmacy/wholesale operations, which neither confirms nor denies the reported franchise talks themselves; New Pharm’s spokesperson likewise declined to comment on the rumour ²⁵. Separately and without denial, the article reports that a Boots purchasing delegation of roughly 10–11 people visited Tel Aviv in June 2008 to buy “innovative products, especially medical ones,” meeting with Ahava Dead Sea Laboratories (described in the article as already supplying Boots with Dead Sea mineral-based cosmetics) and CTS Chemical Industries (pharmaceuticals/medical devices) ²⁵. No article content confirms the New Pharm rebrand was ever consummated, and no subsequent reporting confirming or denying completion of the “Boots Israel” plan was located ²⁵. The haaretz.com and original thejc.com dead links the prior audit flagged as unresolved remain unresolved for the Haaretz side specifically: an archive.org retrieval attempt failed at the tool level (the fetch tool could not reach web.archive.org in this environment, distinct from a content-level 404), so the Haaretz source remains unverified ^{26, 27}.

New Pharm’s later corporate fate is relevant context for whether the 2008 plan could still be live: per search-snippet-level (not independently fetched) Globes reporting, New Pharm was subsequently acquired by Hamashbir 365 Holdings and then by Shufersal in 2017 (reportedly ~ILS 130 million), and rebranded as “Be” in 2018 - meaning the specific would-be Israeli franchise partner named in 2008 no longer exists under that name or under any Boots branding, independent of whatever became of the original talks ²⁸.

A follow-up search for current (2025–2026) evidence of Boots stocking Ahava products again returned no Boots-specific or UK-retailer-specific result; only unrelated European/Australian retailers (Zalando.de, parfumdreams.de, lookfantastic) and Ahava’s own direct channels (now under Fosun International ownership, per Ahava’s Wikipedia page) appeared. A direct attempt to query Boots.com’s own site search for “ahava” was blocked by a bot-detection interstitial page in the prior audit cycle and was not re-attempted this cycle. Consequently, no post-2008 evidence, positive or negative, has been obtained on whether Boots resumed stocking Ahava or any Israeli-settlement-linked product, and that status remains unknown rather than affirmatively resolved ²⁴.

A low-reliability secondary aggregator, aluxurylifestyle.com (“Does Boots Support Israel,” undated but internally dated to late 2024/early 2025), was reviewed and is explicitly flagged as unreliable: it carries an AI-assistance disclosure, asserts without citation that Boots “clearly supports Israel” and “ships supplies for IDF soldiers,” gives internally inconsistent boot-shipment totals (73,000 vs. 65,000 pairs in different sections of the same page), and claims Boots “previously stocked Ahava products” with no source given ²⁹. Its unsupported Boots-specific claims conflate the retailer with “Boots for Israel,” an unrelated US volunteer campaign shipping literal combat boots to IDF soldiers, started by Yakir Wachstock following an IDF Major’s request on 11 October 2023 - a campaign concerning footwear donations with no connection to Boots UK or the pharmacy retailer ²⁹. Per the source-chasing rule for aggregators, none of aluxurylifestyle.com’s unsupported claims are carried into this audit as fact; the only Boots-related content on that page traceable to a verifiable source is the same 2008 JC story already independently verified above ^{25, 29}.

The page separately quotes an Alliance Boots human-rights policy statement committing the company to avoiding complicity in human-rights abuses, but no direct corporate response to the specific franchise or Ahava claims was located ²⁴. Boots is not named in the UN OHCHR settlement-enterprise database per its 2023 and 2025 update documents, though this reflects a document-scoped check rather than a live search of ohchr.org and the database is not represented as a complete register ³⁰. A Business & Human Rights Resource Centre company profile for Walgreens (part of Walgreens Boots Alliance) contains no Israel, Palestine, or defence/military content, addressing only unrelated labor-rights issues ³¹. A Who Profits database search for “Boots” was re-attempted and again returned an inconclusive, unfiltered alphabetical results page (beginning “A. Barkan and Co.,” 24 total pages, no server-side application of the search term) that did not reach entries sorting under “B”; this is the same inconclusive, non-functional search result as the prior audit cycle, so neither presence nor absence on Who Profits could be confirmed ³². A query to the AFSC Investigate database again returned an HTTP 404 identical to the prior cycle’s result, and no content could be retrieved ³³. Separately, unrelated 2014 reporting documented a boycott campaign by UK pharmacy contractors over Teva’s Israel links, with no indication that Boots itself was a subject of that campaign ³⁴.